MedTrace Logo

Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI

NCT06353594 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1272

Last updated 2024-04-09

No results posted yet for this study

Summary

The objective is to compare a reduced stent strategy based on drug-coated balloon (DCB) percutaneous coronary intervention (PCI) with conventional drug-eluting stent (DES) coronary revascularization in patients presenting with ST-segment myocardial infarction (STEMI).

Randomization will be performed after successful culprit-lesion guidewire crossing and flow restoration. Random allocation in a 1:1 fashion to one of the following strategies:

* Study group: reduced stent PCI strategy (DCB-based)
* Control group: conventional PCI strategy (DES-based).

Conditions

  • ST Elevation Myocardial Infarction

Interventions

DEVICE

Primary PCI

Coronary percutaneous revascularization

Sponsors & Collaborators

  • Jorge Sanz Sanchez

    lead OTHER

Principal Investigators

  • Jorge Sanz Sánchez, PI · Hospital Universitario La Fe

  • Ignacio J Amat Santos, PI · Hospital Universitario de Valladolid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-11
Primary Completion
2026-09-30
Completion
2035-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06353594 on ClinicalTrials.gov